Find clinical trials for Breast Cancer in Portland, OR
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Breast Cancer trials near Portland, OR, USA:
The goal of this study is assess the safety and tolerability of the IRX-2 regimen in patients with early stage breast cancer (ESBC) ...
Phase 1
Portland, Oregon, United States
(ICI) on on 3-year Event Free Survival (EFS), in women with residual hormone receptor negative, HER2-negative ("triple negative") resectable breast...
Phase 2
Portland, Oregon, United States and 3 other locations
The goal of this protocol is to evaluate the safety and efficacy of an alternative systemic combination approach that omits or delays the use of chem...
Phase 2
Portland, Oregon, United States and 1 other location
in combination with either of two chemotherapy regimens (weekly paclitaxel or capecitabine) in unresectable/metastatic triple negative breast...
Phase 1, Phase 2
Portland, Oregon, United States and 1 other location
A randomized, Phase II trial of circulating tumor DNA-guided second line Adjuvant therapy for high Residual risk, stage II-III, Estrogen Rec ...
Phase 2
Portland, Oregon, United States and 14 other locations
A Global, Phase 2 Study of ARX788 in HER2-positive Metastatic Breast Cancer Patients who were previously treated with T-DXd...
Phase 2
Portland, Oregon, United States and 62 other locations
to anti-HER2-based therapy plus endocrine therapy alone in improving the outcomes of subjects with hormone receptor-positive, HER2+ metastatic breast...
Phase 3
Portland, Oregon, United States and 117 other locations
together. A side effect is anything a drug does besides treating cancer.Participants in this trial have HER2-positive (HER2+) breast...
Phase 2
Portland, Oregon, United States and 32 other locations
This study to learn more about olaparib and olaparib plus durvalumab combination therapy and also to better understand the studied disease, breast...
Phase 2
Portland, Oregon, United States and 43 other locations
growth factor 2 negative (ER+/HER2-) locally advanced or metastatic breast cancer. The main goals of this study are to:* Identify t...
Phase 1
Vancouver, Washington, United States and 4 other locations
Clinical trials
Research sites
Resources
Legal